Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
September 30, 2026 -0.0605M
June 30, 2026 -0.0468M
March 31, 2026 -0.0637M
December 31, 2025 -0.0784M
September 30, 2025 -0.2578M
June 30, 2025 -0.0357M
March 31, 2025 -0.0474M
December 31, 2024 -0.0546M
September 30, 2024 -0.0786M
June 30, 2024 -0.2011M
March 31, 2024 -0.0699M
Date Value
December 31, 2023 -0.5669M
September 30, 2023 -0.0871M
June 30, 2023 -0.0876M
March 31, 2023 -0.0527M
December 31, 2022 -0.0025M
September 30, 2022 -0.3269M
June 30, 2022 -0.0222M
March 31, 2022 -0.0164M
December 31, 2021 -0.364M
September 30, 2021 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.00
Exicure, Inc. 0.00
Century Therapeutics, Inc. 17.53M
Absci Corp. -67.05M
Celularity, Inc. 0.00